Navigation Links
Biomarkers: Technological and Commercial Outlook 2013-2023
Date:9/2/2013

rdiovascular Biomarker Research4.4.2 The Current State of Cardiovascular Disease Biomarker Research4.4.3 Cardiovascular Disease Diagnostics4.4.4 The Future of Cardiovascular Biomarker Research4.4.5 Cardiovascular Disease Biomarker Submarket: Revenue Forecast, 2013-20234.5 CNS Diseases Biomarker Submarket, 20124.5.1 The Current State of CNS Disease Biomarker Research4.5.2 Biomarker-Based Diagnostics for CNS Diseases4.5.2.1 DiaGenic: Targeting Neurodegenerative Diseases4.5.3 Neuroimaging Biomarkers: Limitations in Sensitivity May Restrict Market4.5.4 CSF Biomarkers: Biochemical Composition of CSF Offers Potential4.5.5 Alzheimer's Disease: Beyond Amyloid Beta4.5.6 Multiple Sclerosis: Search for Disease Biomarker4.5.7 Parkinson's Disease: Effective Biomarker Yet to be Discovered4.5.7.1 Fluid-Based Biomarker Discovery4.5.8 CNS Diseases Biomarker Submarket: Revenue Forecast, 2013-20234.6 Growth in Key Biomarker Indications, 2013-2023

5. Leading National Biomarker Markets, 2013-2023

5.1 The World Biomarkers Market: Regional Breakdown, 2012

5.2 The World Biomarkers Market: Regional Forecast, 2013-2023

5.3 Strong Base for Biomarker Research in US

5.3.1 The US Biomarker Market: Revenue Forecast, 2013-2023

5.4 Top 5 EU Biomarker Markets, 2012

5.4.1 Top 5 EU Biomarker Markets: Revenue Forecasts, 2013-2023

5.4.2 French Government Funds $17m Cancer Biomarker Effort

5.4.2.1 France: Biomarker Market Revenue Forecast, 2013-2023

5.4.3 Focus on Biomarkers Prompts Opening of New Centre in Germany

5.4.3.1 Germany: Biomarker Market Revenue Forecast, 2013-2023

5.4.4 UK: Increased Funding for Biomarker Research

5.4.4.1 The UK Biomarker Market: Revenue Forecast, 2013-2023

5.4.5 Healthcare Cuts Restricting Drug Development in Spain

5.4.5.1 Spain: Biomarker Mar
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Biomarkers: Technological and Commercial Outlook 2012-2022
2. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
3. Lockheed Martin and Nanyang Technological University to collaborate on nanotechnology
4. SCD-iBIO Announces Second International Forum on Commercializing Global Green
5. Micropharma Limited announces new agreement to commercialize novel natural health products
6. Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization
7. John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
8. Leveraging an Academic-Industry Partnership for Commercial Success, New Life Science Webinar Hosted By Xtalks
9. United Airlines and AltAir Fuels to Bring Commercial-Scale, Cost-Competitive Biofuels to Aviation Industry
10. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
11. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... that develops and commercializes proprietary technologies and products for ... results for the second fiscal quarter ended March 31, ... continued to advance business with our existing customers and ... President and CEO of SQI. "The delivery of a ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 uBiome, ... announced a partnership with PicnicHealth, a healthcare company ... Participants diagnosed with Inflammatory Bowel Disease (IBD) will ... a complementary uBiome research kit. Both companies were ... , For more information on this ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 21, 2015 Tunnell Consulting, ... firm as senior statistician and Principal, a position to ... in the management and analysis of complex and large ... industries. , “We’re delighted to have Julia join the ... analytics,” said Dr. Philippe Cini, Group Vice President and ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
... Atrial Fibrillation, EP Mapping and ... Ablation, PCI and Additional Complex Procedures, ST. ... ) announced today that more than 10,000 procedures ... system utilizes,advanced, magnet-guided navigational technology intended to help,electrophysiologists ...
... Alliance On September 10th, 2007 Hard Rock International ... York City. Legendary artist Willie Nelson,and friends will perform ... "save the planet" motto, Hard Rock,s Ambassadors Of Rock ... Biodiesel Alliance. Award-winning,actors Woody Harrelson and Daryl Hannah will ...
... -- China Kangtai,Cactus Biotech, Inc. (OTC Bulletin Board: ... of a variety of cactus-based,consumer products, announced today ... Cactus Health Cigarettes. In order to develop ... Olympiad, and in an effort to take advantage ...
Cached Biology Technology:Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide 2Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide 3MultiVu Video Feed: Hard Rock's 2007 Ambassadors of Rock Tour Is "On the Road Again" With Music Legend Willie Nelson 2China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch 2China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch 3China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch 4
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, reminds investors and media that  Mr. ...  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of nine ... Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... Clinic,s Genomic Medicine Institute have revealed multiple genetic discoveries that ... patients who are predisposed to breast and kidney cancer. ... cancerous tumors, is published in the Dec. 22 issue of ... JAMA ). Charis Eng, M.D., Ph.D, Chair of ...
... The leading causes of death have shifted from infectious diseases ... illnesses may be affected by diet. In a study published ... the American Dietetic Association , researchers investigated empirical data regarding ... the eating patterns of over 2500 adults between the ages ...
... , ARLINGTON, Va. Dubbed the "Brilliant 10" by ... 2010 list of top young scientists have received funding ... two ONR-funded researchers are Dr. Chiara Daraio, a 2010 ... and designed a nonlinear acoustic lens, which has the ...
Cached Biology News:Researchers discover genetic predisposition for breast, kidney cancers 2Eating healthier means living longer 2ONR-funded researchers among Popular Science magazine's 'Brilliant 10' 2
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Mouse monoclonal antibody raised against a partial recombinant NEK2. NCBI Entrez Gene ID = NEK2...
... DS-L2 imaging controller is a successor of ... allows users to comfortably observe, record and ... features an 8.4 inch LCD (XGA) monitor ... Nikon cameras including the DS-Fi1 , DS-5Mc ...
... system for detection of very low level ... Equipped with an extreme sensitive camera to ... plants in tumor research, infectious disease research, ... NightOWL is the only imager with a ...
Biology Products: